Actively Recruiting
Taiwan Severe Asthma Biologic Registry
Led by Taichung Veterans General Hospital · Updated on 2024-06-13
500
Participants Needed
1
Research Sites
1007 weeks
Total Duration
On this page
Sponsors
T
Taichung Veterans General Hospital
Lead Sponsor
E
E-DA Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective multi-centers cohort study for registration adult patients with severe asthma and were reimbursed biologics treatment in Taiwan. The goal of this observational study is to discover the real-world effectiveness, the impact of initiating, switching of biologics, and the possible prediction factors for selecting the best treatment option for patients. The main question\[s\] it aims to answer are: 1. Determine risk factors associated with poor asthma control. 2. Support the development of effectiveness and safety of therapeutic principles 3. To discover the real-world effectiveness of different biologics ( Clinical remission) 4. To discover the impact of initiating biologics for severe asthma patients. 5. To evaluate the prevalence of biologics switching and its benefits for patients. 6. To compare the achievement rate of clinical remission among different biologics. Participants who are treated either with omalizumab, mepolizumab, benralizumab dupilzumab or Tezepelumab after January 1, 2020 will be included in the study.
CONDITIONS
Official Title
Taiwan Severe Asthma Biologic Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide informed consent before any study procedures
- Confirmed severe asthma diagnosis by National Health Insurance Administration or study board
- Male or female aged over 18 years
- Treated with omalizumab, mepolizumab, or benralizumab starting January 1, 2020 or later
You will not qualify if you...
- No informed consent for participation
- Use of biologic treatments before January 1, 2020
- Less than 12 months washout period without biologics or clinical trial participation before starting biologics
- Presence of other lung diseases such as COPD, bronchiectasis, or pulmonary fibrosis
- Exposure to smoking or environmental factors linked to lung or systemic diseases other than asthma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Taichung Veterans General Hospital
Taichung, Taiwan, 40705
Actively Recruiting
Research Team
P
Pin-Kuei Fu, MD.,PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here